Value-based radiotherapy: A new chapter of the ESTRO-HERO project

被引：22
|
作者：
Lievens, Yolande [1 ,2 ]
Borras, Josep-Maria [3 ]
Grau, Cai [4 ,5 ]
Aggarwal, Ajay [6 ,7 ]
机构：
[1] Ghent Univ Hosp, Radiat Oncol Dept, C Heymanslaan 10, B-9000 Ghent, Belgium
[2] Univ Ghent, Ghent, Belgium
[3] Univ Barcelona, IDIBELL, Barcelona, Spain
[4] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[5] Aarhus Univ Hosp, Danish Ctr Particle Therapy, Aarhus, Denmark
[6] Guys & St Thomas NHS Trust, Dept Clin Oncol, London, England
[7] London Sch Hyg & Trop Med, London, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 160卷
关键词：
Value-based; Radiotherapy; Innovation; Outcomes; Evidence; AFFORDABLE CANCER CARE; EUROPEAN-UNION; HEALTH-CARE; RADIATION; COST; ACCESS; DELIVERY; SOCIETY; BENEFIT; BURDEN;
D O I：
10.1016/j.radonc.2021.05.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Radiotherapy interventions are rapidly evolving and improving, holding promise for better patient outcomes, yet at the possible detriment of higher societal costs. The ESTRO-HERO value-based radiotherapy project aims to develop a framework defining and assessing the value of radiotherapy innovations, to support clinical implementation and equitable access, within a sustainable healthcare system. (c) 2021 The Authors. Published by Elsevier B.V. Radiotherapy and Oncology 160 (2021) 236-239 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码：236 / 239
页数：4
相关论文
共 50 条
  • [1] National costs & resource requirements of radiotherapy: costing estimate from the ESTRO-HERO project
    Roques, T.
    Spencer, K.
    Defourny, N.
    Diez, P.
    Francis, A.
    Griffin, S.
    Langmack, K.
    Kirkby, N.
    Mee, T.
    Roe, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S811 - S811
  • [2] The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
    Borras, Josep M.
    Barton, Michael
    Grau, Cai
    Corral, Julieta
    Verhoeven, Rob
    Lemmens, Valery
    van Eycken, Liesbet
    Henau, Kris
    Primic-Zakelj, Maja
    Strojan, Primoz
    Trojanowski, Maciej
    Dyzmann-Sroka, Agnieszka
    Kubiak, Anna
    Gasparotto, Chiara
    Defourny, Noemie
    Malicki, Julian
    Dunscombe, Peter
    Coffey, Mary
    Lievens, Yolande
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 116 (01) : 45 - 50
  • [3] How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis
    Borras, Josep M.
    Lievens, Yolande
    Barton, Michael
    Corral, Julieta
    Ferlay, Jacques
    Bray, Freddie
    Grau, Cai
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 (01) : 5 - 11
  • [4] Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey
    Lievens, Yolande
    Defourny, Noemie
    Coffey, Mary
    Borras, Josep M.
    Dunscombe, Peter
    Slotman, Ben
    Malicki, Julian
    Bogusz, Marta
    Gasparotto, Chiara
    Grau, Cai
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 112 (02) : 178 - 186
  • [5] Cost of the external beam radiotherapy in Catalonia (Spain): an application of the ESTRO-HERO model
    Corral, J.
    Algara, M.
    Munoz-Montplet, C.
    Eraso, A.
    Giralt, J.
    Espinas, J. A.
    Sola, J.
    Defourny, N.
    Lievens, Y.
    Borras, J. M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S30 - S32
  • [6] Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey
    Lievens, Y.
    Coffey, M.
    Defourney, N.
    Dunscombe, P.
    Borras, J.
    Slotman, B.
    Malicki, J.
    Bogusz, M.
    Gasparotto, C.
    Grau, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S222 - S223
  • [7] Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis
    Defourny, Noemie
    Dunscombe, Peter
    Perrier, Lionel
    Grau, Cai
    Lievens, Yolande
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 121 (03) : 468 - 474
  • [8] The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis
    Borras, Josep M.
    Lievens, Yolande
    Dunscombe, Peter
    Coffey, Mary
    Malicki, Julian
    Corral, Julieta
    Gasparotto, Chiara
    Defourny, Noemie
    Barton, Michael
    Verhoeven, Rob
    van Eycken, Liesbeth
    Primic-Zakelj, Maja
    Trojanowski, Maciej
    Strojan, Primoz
    Grau, Cai
    Kokobobo, Arianit
    Sedlmayer, Felix
    De Hertogh, Olivier
    Hadjieva, Tatiana
    Petera, Jiri
    Eriksen, Jesper Grau
    Jaal, Jana
    Azria, David
    Takacsi-Nagy, Zoltan
    Johannsson, Jakob
    Cunningham, Moya
    Atkocius, Vydmantas
    Untereiner, Michel
    Pirotta, Martin
    Karadjinovic, Vanja
    Levernes, Sverre
    Skladowski, Krystof
    Trigo, Maria Lurdes
    Segedin, Barbara
    Cabezas, Sonia Garcia
    Lagerlund, Magnus
    Pastoors, Bert
    Slotman, Ben
    Beardmore, Charlotte
    Smyth, Gaile
    Vaarkamp, Jaap
    Dyzmann-Sroka, Agnieszka
    Kubiak, Anna
    Henau, Kris
    Lemmens, Valery
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 116 (01) : 38 - 44
  • [9] How public health services pay for radiotherapy in Europe: an ESTRO-HERO analysis of reimbursement
    Lievens, Yolande
    Defourny, Noemie
    Corral, Julieta
    Gasparotto, Chiara
    Grau, Cai
    Borras, Josep Maria
    [J]. LANCET ONCOLOGY, 2020, 21 (01): : E42 - E54
  • [10] Radiotherapy departments and equipment in the European countries: Final results from the ESTRO-HERO survey
    Grau, C.
    Defourney, N.
    Malicki, J.
    Dunscombe, P.
    Borras, J. M.
    Coffey, M.
    Slotman, B.
    Bogusz, M.
    Gasparotto, C.
    Lievens, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S222 - S222
12345